| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,444 |
4,685 |
$548K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,093 |
6,189 |
$496K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,817 |
3,793 |
$299K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,708 |
2,495 |
$114K |
| 99442 |
|
741 |
674 |
$54K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
368 |
367 |
$46K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
430 |
429 |
$42K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,222 |
1,119 |
$31K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
556 |
520 |
$24K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,917 |
1,698 |
$21K |
| 99443 |
|
134 |
126 |
$14K |
| 99000 |
|
4,030 |
3,654 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
910 |
887 |
$12K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
107 |
106 |
$12K |
| 99406 |
|
1,091 |
907 |
$10K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
203 |
202 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
221 |
210 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
1,481 |
1,420 |
$5K |
| 96127 |
|
1,130 |
1,094 |
$4K |
| 99215 |
Prolong outpt/office vis |
31 |
29 |
$4K |
| 99385 |
|
31 |
30 |
$3K |
| 99001 |
|
644 |
593 |
$3K |
| 99441 |
|
48 |
44 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,080 |
1,000 |
$2K |
| 0001A |
|
35 |
35 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
753 |
703 |
$755.29 |
| 81003 |
|
408 |
384 |
$746.60 |
| 0002A |
|
16 |
16 |
$535.97 |
| 81002 |
|
100 |
93 |
$287.18 |
| 1159F |
|
1,421 |
1,292 |
$0.77 |
| 1160F |
|
831 |
789 |
$0.73 |
| 3074F |
|
151 |
146 |
$0.22 |
| 3078F |
|
146 |
140 |
$0.19 |
| 3077F |
|
132 |
126 |
$0.18 |
| 3079F |
|
112 |
105 |
$0.13 |
| 3080F |
|
42 |
41 |
$0.08 |
| 3075F |
|
64 |
61 |
$0.06 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,178 |
1,058 |
$0.00 |
| 99072 |
|
132 |
122 |
$0.00 |
| 4004F |
|
405 |
328 |
$0.00 |
| 91300 |
|
87 |
84 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
400 |
392 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
273 |
243 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
401 |
322 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
484 |
456 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
13 |
12 |
$0.00 |
| 91301 |
|
14 |
14 |
$0.00 |